Superworth

Assembly Biosciences EPS ASMB

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
−$0.15
Latest quarter, Q2 FY26
−$0.20
Fiscal year 2025
−$1.91

Assembly Biosciences' earnings per share was −$0.15 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.20.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$1.91n/a
FY2024−$6.73n/a
FY2023−$13.69n/a
FY2022−$23.16n/a
FY2021−$35.88n/a
FY2020−$21.12n/a
FY2019−$44.64n/a
FY2018−$48.00n/a
FY2017−$29.52n/a
FY2016−$30.84n/a
FY2015−$22.56n/a
FY2014−$40.32n/a
FY2013−$59.76n/a
FY2012−$117.00n/a
FY2011−$202.20n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.20n/a−$0.15
Q1 FY26−$0.54n/a−$1.28
Q4 FY25$1.31n/a−$1.91
Q3 FY25−$0.72n/a−$4.80
Q2 FY25−$1.33n/a−$5.59
Q1 FY25−$1.17n/a−$6.24
Q4 FY24−$1.58n/a−$6.73
Q3 FY24−$1.51n/a−$7.21
Q2 FY24−$1.98n/a−$8.99
Q1 FY24−$1.66n/a−$10.89
Q4 FY23−$2.06n/a−$13.69
Q3 FY23−$3.29n/a−$17.15

Against its peers

Companies in Drug Manufacturers - General nearest Assembly Biosciences' size, closest first, today.

CompanyEPS, 12 monthsGrowth
ASMBAssembly Biosciences−$0.15
ARVNArvinas$0.16
PBYIPuma Biotechnology$0.52−47% a year
IRWDIronwood Pharmaceuticals$0.77
ZVRAZevra Therapeutics$0.93
CRMDCorMedix$2.13+184% a year
COLLCollegium Pharmaceutical$1.24+19% a year
NATRNatures Sunshine Products$1.01+36% a year
ABUSArbutus Biopharma$0.78
AMPHAmphastar Pharmaceuticals$1.70−36% a year
OMEROmeros$1.52
Peer median$0.97

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Assembly Biosciences

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.